AirDuo Digihaler Interactions
There are 463 drugs known to interact with AirDuo Digihaler (fluticasone/salmeterol), along with 11 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 55 are major, 391 are moderate, and 17 are minor.
- View all 463 medications that may interact with AirDuo Digihaler
- View AirDuo Digihaler alcohol/food interactions (2)
- View AirDuo Digihaler disease interactions (11)
Most frequently checked interactions
View interaction reports for AirDuo Digihaler (fluticasone / salmeterol) and the medicines listed below.
- acetaminophen
- Adderall (amphetamine / dextroamphetamine)
- albuterol
- amlodipine
- atorvastatin
- Benadryl (diphenhydramine)
- carvedilol
- cetirizine
- CoQ10 (ubiquinone)
- cyclobenzaprine
- escitalopram
- famotidine
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flovent HFA (fluticasone)
- fluticasone nasal
- gabapentin
- ibuprofen
- levocetirizine
- levothyroxine
- magnesium glycinate
- metformin
- methocarbamol
- montelukast
- nitrofurantoin
- omeprazole
- pantoprazole
- prednisone
- sertraline
- Singulair (montelukast)
- Vitamin D3 (cholecalciferol)
AirDuo Digihaler alcohol/food interactions
There are 2 alcohol/food interactions with AirDuo Digihaler (fluticasone / salmeterol).
AirDuo Digihaler disease interactions
There are 11 disease interactions with AirDuo Digihaler (fluticasone / salmeterol) which include:
- cardiovascular
- diabetes
- hypokalemia
- seizures
- hepatic impairment
- infections
- ocular herpes simplex
- ocular toxicities
- osteoporosis
- hyperadrenocorticism
- hepatic dysfunction
Report options
More about AirDuo Digihaler (fluticasone / salmeterol)
- AirDuo Digihaler consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: bronchodilator combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.